1 |
Abatacept
| 2件: ABATACEPT ABATACEPT; Orencia | 1件: D03203
D03203
| 2件: CD80 CD80, CD86 💬 | 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 11 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 |
2 |
Acetaminophen
| 4件: Acetaminophen Acetaminophen; PARACETAMOL; Tylenol; Ultracet | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 15件: 3 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 |
3 |
Aluminium
| 2件: Aluminium Aluminium; Aluminum | - | - | - | 2件: 11 11, 46 |
4 |
Aluminum hydroxide
| 2件: Aluminium hydroxide Aluminium hydroxide; Aluminum hydroxide | 1件: D02416
D02416
| - | - | 2件: 11 11, 46 |
5 |
Amifampridine
| 2件: Amifampridine Amifampridine; Firdapse | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 |
6 |
Apraclonidine
| 1件: Apraclonidine Apraclonidine | 1件: D07461
D07461
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
7 |
Azathioprine
| 3件: Azathioprine Azathioprine; AZATIOPRINA; Imuran | 1件: D00238
D00238
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
8 |
Batoclimab
| 1件: Batoclimab Batoclimab | 1件: D11983
D11983
| 1件: FCGRT FCGRT 💬 | - | 2件: 11 11, 14 |
9 |
Belimumab
| 2件: Belimumab Belimumab; BENLYSTA | 1件: D03068
D03068
| 1件: TNFSF13B TNFSF13B 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 13件: 11 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 |
10 |
Bortezomib
| 3件: Bortezomib Bortezomib; Bortezomib Accord; Velcade | 1件: D03150
D03150
| 1件: PSMB5 PSMB5 💬 | 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 |
11 |
Bortezomib D-mannitol
| 3件: BORTEZOMIB BORTEZOMIB; Bortezomib D-mannitol; Velcade | - | - | - | 3件: 11 11, 28, 61 |
12 |
Carmustine
| 1件: Carmustine Carmustine | 1件: D00254
D00254
| - | - | 5件: 11 11, 13, 14, 28, 60 |
13 |
Cemdisiran
| 1件: Cemdisiran Cemdisiran | - | - | - | 4件: 11 11, 62, 66, 109 |
14 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
15 |
Cladribine
| 4件: 2-CdA 2-CdA; CLADRIBINA; CLADRIBINE; MAVENCLAD | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 3件: 11 11, 13, 94 |
16 |
Coenzyme M
| 2件: MESNA MESNA; UROMITEXAN | - | - | - | 10件: 11 11, 13, 44, 45, 51, 60, 65, 85, 96, 164 |
17 |
Corynebacterium diphtheriae
| 1件: Corynebacterium diphtheriae Corynebacterium diphtheriae | - | - | - | 1件: 11 11 |
18 |
Corynebacterium diphtheriae CRM197 protein
| 1件: CRM197 CRM197 | - | - | - | 3件: 11 11, 13, 46 |
19 |
CV-MG01
| 1件: CV-MG01 CV-MG01 | - | - | - | 1件: 11 11 |
20 |
Cyclophosphamide
| 6件: Ciclofosfamida Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamidum; Cytoxan | 2件: D00287
D00287
,
D07760
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 |
21 |
Cyclosporine
| 10件: Ciclosporin Ciclosporin; Ciclosporina; Ciclosporine; Cyclosporin; Cyclosporin A; Cyclosporine; Cyclosporine A; Ikervis; Neoral; Restasis | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 44件: 11 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
22 |
Cytarabine
| 1件: Cytarabine Cytarabine | 1件: D00168
D00168
| - | - | 7件: 11 11, 13, 14, 25, 49, 60, 65 |
23 |
Diphenhydramine
| 2件: Diphenhydramine Diphenhydramine; Diphenhydramine hydrochloride | 1件: D00300
D00300
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 8件: 11 11, 13, 49, 51, 70, 86, 222, 256 |
24 |
Eculizumab
| 2件: ECULIZUMAB ECULIZUMAB; SOLIRIS | 1件: D03940
D03940
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 11 11, 13, 14, 61, 62, 109, 222 |
25 |
Efalizumab
| 2件: Efalizumab Efalizumab; Raptiva | 1件: D03959
D03959
| 1件: ITGAL ITGAL 💬 | 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 9件: 11 11, 13, 37, 46, 49, 53, 61, 95, 96 |
26 |
Efgartigimod alfa
| 1件: EFGARTIGIMOD ALFA EFGARTIGIMOD ALFA | 1件: D11876
D11876
| 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 35, 53, 63, 162 |
27 |
Ephedrine
| 3件: Efedrina Efedrina; Ephedrine; EPHEDRINE HYDROCHLORIDE | 1件: D00124
D00124
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 11 11 |
28 |
Etoposide
| 1件: Etoposide Etoposide | 1件: D00125
D00125
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 |
29 |
Famciclovir
| 1件: Famciclovir Famciclovir | 1件: D00317
D00317
| - | - | 2件: 11 11, 13 |
30 |
Filgrastim
| 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; GRANULOCYTE COLONY STIMULATING FACTOR; Neupogen; TEVAGRASTIM; Zarzio | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
31 |
Fludarabine
| 4件: FLUDARA FLUDARA; Fludarabina; FLudarabine; Fludarabine phosphate | 1件: D07966
D07966
| 1件: RRM1 RRM1 💬 | 6件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 20件: 11 11, 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
32 |
Human immunoglobulin G
| 19件: Bivigam Bivigam; CUTAQUIG; CUVITRU; GAMMAGARD LIQUID; Gammaplex; GAMUNEX-C; Hizentra; Human Immunoglobulin G; Human normal immunoglobulin; HyQvia; Immune globulin; Immunoglobulin; IMMUNOGLOBULIN G; IVIg; KIOVIG; Octagam; PANZYGA; Privigen; Vivaglobin | - | - | - | 10件: 11 11, 13, 14, 17, 43, 45, 50, 51, 63, 65 |
33 |
Hydroxide ion
| 2件: Example Example; Hydroxide | - | - | - | 6件: 5 5, 11, 46, 96, 97, 284 |
34 |
Inebilizumab
| 2件: Inebilizumab Inebilizumab; Uplizna | 1件: D11757
D11757
| 1件: CD19 CD19 💬 | 5件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | 4件: 11 11, 13, 51, 300 |
35 |
Iron polymaltose
| 1件: Fusion Fusion | - | - | - | 9件: 11 11, 13, 46, 49, 69, 70, 86, 271, 299 |
36 |
Isoxaflutole
| 1件: Balance Balance | - | - | - | 5件: 6 6, 11, 46, 81, 149 |
37 |
Lactobacillus casei
| 2件: Fusion Fusion; Lactobacillus casei | 1件: D04351
D04351
| - | - | 10件: 6 6, 11, 13, 46, 49, 69, 70, 97, 271, 296 |
38 |
Leflunomide
| 3件: ARAVA ARAVA; Leflunomide; Leflunomidum | 1件: D00749
D00749
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 12件: 11 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300 |
39 |
Magnesium
| 1件: Magnesium Magnesium | - | - | - | 19件: 6 6, 11, 13, 46, 51, 63, 64, 70, 93, 97, 111, 166, 225, 235, 284, 291, 296, 297, 298 |
40 |
Magnesium sulfate
| 1件: Magnesium sulfate Magnesium sulfate | 1件: D01108
D01108
| - | - | 3件: 11 11, 296, 297 |
41 |
Melphalan
| 3件: Alkeran Alkeran; Melphalan; Melphalan Hydrochloride | 1件: D00369
D00369
| - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
42 |
Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine
| 1件: MENVEO MENVEO | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
43 |
Meningococcal polysaccharide vaccine group A
| 2件: MENVEO MENVEO; Nimenrix | 1件: D04910
D04910
| - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 |
44 |
Meningococcal polysaccharide vaccine group C
| 2件: Menveo Menveo; Nimenrix | 1件: D06415
D06415
| - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 |
45 |
Meningococcal polysaccharide vaccine group W-135
| 2件: MENVEO MENVEO; Nimenrix | - | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 |
46 |
Meningococcal polysaccharide vaccine group Y
| 2件: Menveo Menveo; Nimenrix | - | - | - | 7件: 11 11, 13, 50, 61, 62, 66, 222 |
47 |
Methamidophos
| 1件: MONITOR MONITOR | - | - | - | 4件: 2 2, 11, 81, 129 |
48 |
Methotrexate
| 6件: Methotrexat Methotrexat; METHOTREXATE; METHOTREXATE SODIUM; Metoject; METOTREXATO; Méthotrexate | 1件: D00142
D00142
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
49 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
50 |
Monarsen
| 1件: MONARSEN MONARSEN | - | - | - | 1件: 11 11 |
51 |
Mycophenolate mofetil
| 3件: CellCept CellCept; Mycophenolate mofetil; Mycophenolate mofetil TEVA | 1件: D00752
D00752
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
52 |
Mycophenolic acid
| 5件: Acido Micofenolico Acido Micofenolico; MICOFENOLICO ACIDO; Mycophenolate; Mycophenolic Acid; Myfortic | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
53 |
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: MENVEO MENVEO | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
54 |
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: Menveo Menveo | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
55 |
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: MENVEO MENVEO | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
56 |
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen
| 1件: MENVEO MENVEO | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
57 |
Neisseria meningitidis serogroup b fhbp fusion protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
58 |
Neisseria meningitidis serogroup b nada protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
59 |
Neisseria meningitidis serogroup b nhba fusion protein antigen
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
60 |
Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle
| 1件: Bexsero Bexsero | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
61 |
Nipocalimab
| 1件: Nipocalimab Nipocalimab | 1件: D11666
D11666
| 1件: FCGRT FCGRT 💬 | - | 6件: 11 11, 14, 46, 49, 53, 61 |
62 |
Oxaloacetic acid
| 1件: Oxaloacetate Oxaloacetate | - | - | - | 2件: 6 6, 11 |
63 |
Phosphate ion
| 1件: Phosphate Phosphate | - | - | - | 32件: 2 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
64 |
Pixantrone
| 1件: Pixantrone Pixantrone | 1件: D05522
D05522
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 2件: 11 11, 13 |
65 |
Pozelimab
| 1件: Pozelimab Pozelimab | 1件: D11477
D11477
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 2件: 11 11, 62 |
66 |
Prednisolone
| 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
67 |
Prednisone
| 3件: Prednisona Prednisona; Prednisone; RAYOS | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 |
68 |
Pyridostigmine
| 3件: Mestinon Mestinon; Pyridostigmine; Pyridostigmine Bromide | - | - | - | 4件: 3 3, 6, 11, 256 |
69 |
Rabbit
| 1件: Rabbit Rabbit | - | - | - | 8件: 11 11, 13, 49, 51, 60, 65, 96, 285 |
70 |
Ravulizumab
| 2件: RAVULIZUMAB RAVULIZUMAB; Ultomiris | 1件: D11054
D11054
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 |
71 |
Resiniferatoxin
| 0件: | - | - | - | 5件: 11 11, 46, 65, 222, 240 |
72 |
Rituximab
| 6件: MabThera MabThera; Rituxan; Rituximab; Rixathon; Ruxience; Truxima | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 48件: 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
73 |
Rozanolixizumab
| 1件: ROZANOLIXIZUMAB ROZANOLIXIZUMAB | 1件: D12182
D12182
| 1件: FCGRT FCGRT 💬 | - | 3件: 11 11, 14, 63 |
74 |
Salbutamol
| 3件: Albuterol Albuterol; Salbutamol; Ventolin | 1件: D02147
D02147
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 3 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 |
75 |
Satralizumab
| 3件: Enspryng Enspryng; Sapelizumab; Satralizumab | 1件: D11079
D11079
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 11 11, 13, 86 |
76 |
Sodium chloride
| 6件: Lactated Ringers Lactated Ringers; Natriumchlorid; REBIF; Saline; Sodium chloride; SPORANOX | 1件: D02056
D02056
| - | - | 20件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 |
77 |
Sulfate ion
| 1件: Sulfate Sulfate | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 |
78 |
Tacrolimus
| 2件: Prograf Prograf; Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
79 |
Tocilizumab
| 3件: ACTEMRA ACTEMRA; RoActemra; TOCILIZUMAB | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
80 |
Tofacitinib
| 4件: Tasocitinib Tasocitinib; Tofacitinib; XELJANZ; Xeljanz XR | 1件: D09970
D09970
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 15件: 11 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300 |
81 |
Zilucoplan
| 1件: ZILUCOPLAN ZILUCOPLAN | 1件: D12357
D12357
| 1件: C5 C5 💬 | 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 3件: 2 2, 11, 62 |